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Regulation of intramitochondrial free calcium ([Ca2+]m) is critical in
both physiological and pathological functioning of the heart. The full
extent and importance of the role of [Ca2+]m is becoming apparent as
evidenced by the increasing interest andwork in this area of the last two
decades. However, controversies remain, such as the existence of beat-
to-beatmitochondrial Ca2+ transients; the role of [Ca2+]m inmodulating
whole-cell Ca2+ signalling; whether or not an increase in [Ca2+]m is
essential to couple ATP supply and demand; and the role of [Ca2+]m in
cell death by both necrosis and apoptosis, especially in formation of the
mitochondrial permeability transition pore. The role of [Ca2+]m in heart
failure is an area that has also recently been highlighted. [Ca2+]m can
now be measured reasonably specifically in intact cells and hearts
thanks to developments in fluorescent indicators and targeted proteins
andmore sensitive imaging technology. This has revealed interactions of
the mitochondrial Ca2+ transporters with those of the sarcolemma and
sarcoplasmic reticulum, and has gone a long way to bringing the
mitochondrial Ca2+ transporters to the forefront of cardiac research.
Mitochondrial Ca2+ uptake occurs via the ruthenium red sensitive Ca2+
uniporter (mCU), and efflux via an Na+/Ca2+ exchanger (mNCX). The
purification and cloning of the transporters, and development of more
specific inhibitors,would produce a step-change in our understandingof
the role of these apparently critical but still elusive proteins. In this
article I will summarise the key physiological roles of [Ca2+]m in ATP
production and cell Ca2+ signalling in both adult and neonatal hearts, as
well as highlighting some of the controversies in these areas. I will also
briefly discuss recent ideas on interactions of nitric oxide with [Ca2+]m.
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Mitochondria are the central coordinators of energy metabolism and
alterations in their function and number have long been associated with
metabolic disorders such as obesity, diabetes and hyperlipidemias. Since
oxidative phosphorylation requires an electrochemical gradient across
the inner mitochondrial membrane, ion channels in this membrane
certainly must play an important role in the regulation of energy
metabolism. However, in many experimental settings, the relationship
between the activity of mitochondrial ion transport and metabolic
disorders is still poorly understood. We will cover aspects of mitochon-
drial H+ and K+ transport which may be determinants in metabolic
disorders, including the impact of mitochondrial uncoupling on energy
metabolismandaging and the role of K+channels inmetabolic disorders.
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Mitochondrial carriers link the biochemical pathways of the cytosol
and mitochondrial matrix by transporting substrates across the
mitochondrial inner membrane [1]. The structures of mitochondrial
carriers are three-fold pseudo-symmetrical [2,3], but their substrates
and coupling ions are not. Thus, deviations from symmetry are to be
expected in the substrate and ion binding sites in the central aqueous
cavity [4]. By analyzing the three-fold pseudo-symmetrical repeats from
which their sequences are made, conserved asymmetric residues were
found to cluster in a region of the central cavity identified previously as
the common substrate binding site [5,6]. Conserved symmetrical
residues required for the transport mechanism were found at the
water–membrane interfaces, flanking the substrate binding sites [4].
Three PX[DE]XX[RK] motifs form a salt bridge network on the matrix
side of the cavity, when the carrier is in the cytoplasmic state with the
substrate binding site open to the mitochondrial intermembrane space
[3,7]. Three [FY][DE]XX[RK]motifs arepresenton the cytoplasmic sideof
the cavity and they could form a salt bridge network when the carrier is
in the matrix state with the substrate binding site accessible from the
mitochondrial matrix [4]. It is proposed that the opening and closing of
the carrier could be coupled to the disruption and formation of the two
salt bridge networks induced by substrate binding. The interaction
energy of the cytoplasmic network allows members of the transporter
family to be classified as strict exchangers or importers.
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